Antiproliferative activity of Pt(IV) complexes with lonidamine and bexarotene ligands attached via succinate-ethylenediamine linker

Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects

Ana-Maria Florea, Dietrich Büsselberg · Cancers · 2011 · 1.8K citations · Full text

Medicine, Oncology, Pharmacology +17

The status of platinum anticancer drugs in the clinic and in clinical trials

Nial Wheate, Shonagh Walker, Gemma E. Craig et al. · Dalton Transactions · 2010 · 1.6K citations

Medicine, Oncology, Pharmacology +15

Targeted Single-Wall Carbon Nanotube-Mediated Pt(IV) Prodrug Delivery Using Folate as a Homing Device

Shanta Dhar, Zhuang Liu, Jürgen Thomale et al. · Journal of the American Chemical Society · 2008 · 695 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.

Madeleine Duvic, Ángel G. Martín, Y. Kim et al. · PubMed · 2001 · 438 citations

Medicine, Pharmacology, Pharmacotherapy +14

Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery

Yao‐Rong Zheng, Kogularamanan Suntharalingam, Timothy C. Johnstone et al. · Journal of the American Chemical Society · 2014 · 435 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17